Annual Revenue
$147.75 M
+$7.02 M+4.99%
December 31, 2023
Summary
- As of February 20, 2025, FGEN annual revenue is $147.75 million, with the most recent change of +$7.02 million (+4.99%) on December 31, 2023.
- During the last 3 years, FGEN annual revenue has fallen by -$28.57 million (-16.20%).
- FGEN annual revenue is now -42.41% below its all-time high of $256.58 million, reached on December 31, 2019.
Performance
FGEN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$46.33 M
-$4.31 M-8.51%
September 30, 2024
Summary
- As of February 20, 2025, FGEN quarterly revenue is $46.33 million, with the most recent change of -$4.31 million (-8.51%) on September 30, 2024.
- Over the past year, FGEN quarterly revenue has increased by +$19.20 million (+70.73%).
- FGEN quarterly revenue is now -75.81% below its all-time high of $191.57 million, reached on June 30, 2019.
Performance
FGEN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$180.01 M
+$6.20 M+3.57%
September 30, 2024
Summary
- As of February 20, 2025, FGEN TTM revenue is $180.01 million, with the most recent change of +$6.20 million (+3.57%) on September 30, 2024.
- Over the past year, FGEN TTM revenue has increased by +$32.26 million (+21.84%).
- FGEN TTM revenue is now -49.53% below its all-time high of $356.66 million, reached on September 30, 2019.
Performance
FGEN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
FGEN Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.0% | +70.7% | +21.8% |
| 3 y3 years | -16.2% | +70.7% | +21.8% |
| 5 y5 years | -30.6% | +70.7% | +21.8% |
FGEN Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.2% | +5.0% | -23.8% | +194.5% | -31.6% | +55.1% |
| 5 y | 5-year | -42.4% | +5.0% | -70.3% | +481.1% | -36.6% | +66.0% |
| alltime | all time | -42.4% | +124.1% | -75.8% | +481.1% | -49.5% | +152.7% |
FibroGen Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $46.33 M(-8.5%) | $180.01 M(+3.6%) |
| Jun 2024 | - | $50.64 M(-9.4%) | $173.81 M(+3.8%) |
| Mar 2024 | - | $55.90 M(+106.0%) | $167.49 M(+13.4%) |
| Dec 2023 | $147.75 M(+5.0%) | $27.14 M(-32.4%) | $147.75 M(-4.7%) |
| Sep 2023 | - | $40.13 M(-9.4%) | $154.98 M(+18.7%) |
| Jun 2023 | - | $44.32 M(+22.6%) | $130.58 M(+12.5%) |
| Mar 2023 | - | $36.16 M(+5.2%) | $116.07 M(-17.5%) |
| Dec 2022 | $140.73 M(-40.2%) | $34.37 M(+118.4%) | $140.74 M(+14.5%) |
| Sep 2022 | - | $15.73 M(-47.2%) | $122.91 M(-53.3%) |
| Jun 2022 | - | $29.81 M(-51.0%) | $263.15 M(+2.1%) |
| Mar 2022 | - | $60.83 M(+267.7%) | $257.71 M(+9.5%) |
| Dec 2021 | $235.31 M(+33.5%) | $16.54 M(-89.4%) | $235.31 M(-17.1%) |
| Sep 2021 | - | $155.97 M(+540.2%) | $283.76 M(+65.1%) |
| Jun 2021 | - | $24.36 M(-36.6%) | $171.82 M(-9.7%) |
| Mar 2021 | - | $38.43 M(-40.9%) | $190.35 M(+8.0%) |
| Dec 2020 | $176.32 M(-31.3%) | $65.00 M(+47.6%) | $176.32 M(+47.8%) |
| Sep 2020 | - | $44.03 M(+2.7%) | $119.30 M(+10.0%) |
| Jun 2020 | - | $42.89 M(+75.8%) | $108.44 M(-57.8%) |
| Mar 2020 | - | $24.40 M(+206.0%) | $257.12 M(+0.2%) |
| Dec 2019 | $256.58 M(+20.5%) | $7.97 M(-76.0%) | $256.58 M(-28.1%) |
| Sep 2019 | - | $33.17 M(-82.7%) | $356.66 M(+1.2%) |
| Jun 2019 | - | $191.57 M(+702.8%) | $352.51 M(+72.0%) |
| Mar 2019 | - | $23.86 M(-77.9%) | $204.90 M(-3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $212.96 M(+62.6%) | $108.06 M(+272.3%) | $212.96 M(+57.0%) |
| Sep 2018 | - | $29.03 M(-34.0%) | $135.64 M(-7.8%) |
| Jun 2018 | - | $43.95 M(+37.7%) | $147.16 M(+10.3%) |
| Mar 2018 | - | $31.93 M(+3.9%) | $133.48 M(+1.9%) |
| Dec 2017 | $131.00 M(-28.5%) | $30.74 M(-24.2%) | $131.00 M(-3.5%) |
| Sep 2017 | - | $40.55 M(+34.0%) | $135.78 M(+8.3%) |
| Jun 2017 | - | $30.27 M(+2.8%) | $125.34 M(-32.0%) |
| Mar 2017 | - | $29.44 M(-17.1%) | $184.35 M(+0.6%) |
| Dec 2016 | $183.19 M(+1.3%) | $35.52 M(+18.0%) | $183.19 M(+6.4%) |
| Sep 2016 | - | $30.10 M(-66.3%) | $172.11 M(+6.5%) |
| Jun 2016 | - | $89.28 M(+215.7%) | $161.54 M(-16.2%) |
| Mar 2016 | - | $28.28 M(+15.7%) | $192.81 M(+6.6%) |
| Dec 2015 | $180.83 M(+31.4%) | $24.44 M(+25.1%) | $180.83 M(+4.8%) |
| Sep 2015 | - | $19.54 M(-83.8%) | $172.49 M(+3.5%) |
| Jun 2015 | - | $120.55 M(+639.7%) | $166.62 M(+22.5%) |
| Mar 2015 | - | $16.30 M(+1.2%) | $136.02 M(-1.1%) |
| Dec 2014 | $137.60 M(+34.7%) | $16.11 M(+17.9%) | $137.60 M(+2.8%) |
| Sep 2014 | - | $13.66 M(-84.8%) | $133.89 M(-30.1%) |
| Jun 2014 | - | $89.96 M(+403.2%) | $191.47 M(+88.6%) |
| Mar 2014 | - | $17.88 M(+44.3%) | $101.51 M(+21.4%) |
| Dec 2013 | $102.17 M(+55.0%) | $12.39 M(-82.6%) | $83.64 M(+17.4%) |
| Sep 2013 | - | $71.25 M | $71.25 M |
| Dec 2012 | $65.93 M | - | - |
FAQ
- What is FibroGen annual revenue?
- What is the all time high annual revenue for FibroGen?
- What is FibroGen annual revenue year-on-year change?
- What is FibroGen quarterly revenue?
- What is the all time high quarterly revenue for FibroGen?
- What is FibroGen quarterly revenue year-on-year change?
- What is FibroGen TTM revenue?
- What is the all time high TTM revenue for FibroGen?
- What is FibroGen TTM revenue year-on-year change?
What is FibroGen annual revenue?
The current annual revenue of FGEN is $147.75 M
What is the all time high annual revenue for FibroGen?
FibroGen all-time high annual revenue is $256.58 M
What is FibroGen annual revenue year-on-year change?
Over the past year, FGEN annual revenue has changed by +$7.02 M (+4.99%)
What is FibroGen quarterly revenue?
The current quarterly revenue of FGEN is $46.33 M
What is the all time high quarterly revenue for FibroGen?
FibroGen all-time high quarterly revenue is $191.57 M
What is FibroGen quarterly revenue year-on-year change?
Over the past year, FGEN quarterly revenue has changed by +$19.20 M (+70.73%)
What is FibroGen TTM revenue?
The current TTM revenue of FGEN is $180.01 M
What is the all time high TTM revenue for FibroGen?
FibroGen all-time high TTM revenue is $356.66 M
What is FibroGen TTM revenue year-on-year change?
Over the past year, FGEN TTM revenue has changed by +$32.26 M (+21.84%)